Film creditsThe denominator changes the question.
A data method for keeping dry polymer, wet preparation, sample solution and final assay concentration distinct before comparing material performance.
Proposed evidence-engineering direction | External sources and defined methods; scope, rights and delivery capacity to be agreed.
A dose needs a defined substance
Identify the substance and experimental stage behind a concentration label before treating equal numerical doses as comparable treatments.
Two records labelled with the same concentration can describe different experiments. One may refer to dry polymer mass, another to the recovered powder including residuals, and another to a stock solution before mixing. The proposed concentration record would identify the substance, numerator, denominator and stage of the assay. It would preserve the original wording before any conversion. A formulator could then decide whether a comparison needs matched dry solids, matched total preparation mass or another application-specific basis. Choosing that basis is part of the experiment, not an administrative clean-up after a favourable result appears.
Examine the development decision
The denominator changes the question.
Open the sequence to examine what a development decision needs.
Identify the exact preparation, its source, and the properties a second laboratory must be able to reproduce.
Explanatory geometry · no simulated or measured performance
Sample concentration is not final reaction concentration
Follow the sample into the reaction mixture to distinguish its prepared concentration from the amount present during measurement.
Sun et al. (2015) report crude-EPS chemical assays with specified sample solutions that are subsequently mixed with different reagents. The source sample label must therefore remain separate from a final reaction-mixture concentration derived from the mixing volumes. The working atlas already retains that distinction. A proposed extended dataset would record both quantities only when the method supports the conversion, with the volume basis and any assumptions attached. This gives an assay developer a reproducible comparison and prevents a headline dose from being carried into another reaction mixture as though it had the same meaning.
Dilution arithmetic requires its conditions
Check stock identity and volume assumptions before using dilution arithmetic to reconstruct the concentration relevant to the endpoint.
For an additive solution with a defined stock concentration, mass balance can describe a simple dilution. The relation is useful only when the conserved quantity and volume assumptions are clear. It does not resolve polymer purity, insoluble fractions or a changing chemical species. An enzyme assay may also require a molar catalyst concentration rather than total protein mass, a distinction covered by STRENDA reporting fields (STRENDA Commission, 2021). The proposed record would show the arithmetic and its required inputs beside the original method, keeping an unavailable density or purity correction unresolved rather than hiding it inside a convenient conversion.
A mass-concentration dilution where stock solute is conserved.
- Final mass concentrationkg m⁻³
- Stock mass concentrationkg m⁻³
- Stock volume addedm³
- Measured or justified final volumem³
Model conditions. Same conserved solute; no loss or reaction Use actual final volume or an explicitly justified additive-volume approximation
Keep the conditions attached to the result.
Make scientific records useful through source-linked comparisons, explicit units and a reproducible decision trail.
Dry and wet preparations answer different questions
Separate water, residual components and characterised material when choosing a mass basis for recovered biological preparations and their comparators.
A material recovered from culture can contain water and residual non-polymer matter. A wet-preparation mass basis may be useful for manufacturing handling, while a dry-polymer basis may be more suitable for a molecular comparison. These are not automatically convertible. The proposed record would ask whether water content and relevant purity were measured, and retain their uncertainty if a conversion is justified. JCGM’s measurement framework provides the basis for treating those inputs as measured quantities rather than exact constants (JCGM, 2008). The buyer can then see whether an apparently precise performance ratio depends mostly on an uncertain solids correction.
A familiar concentration can still hide preparation differences
Read concentration alongside specimen preparation, because matching a percentage does not establish equivalent materials or measurement histories.
Woodbridge et al. (2025) identify their Carbopol microgel as 2 g/L. That label is valuable preparation context, but it does not make a body lotion with unknown composition an equivalent polymer-dose comparison. The two source specimens can be compared at a common measured shear rate, while a causal claim about polymer content would need more information and a different design. The proposed concentration view would make that distinction visible. It would support descriptive rheology comparison without pretending that a complete formulation can be reduced to a concentration matching rule inferred from its ingredient name.
Preserve uncertainty through the conversion
Carry weighing, volume and composition uncertainty into a converted dose so that arithmetic precision does not conceal experimental ambiguity.
A converted concentration should retain the uncertainty in weighing, volume, water fraction and any purity estimate. Where the same stock contributes to several conditions, those observations may share uncertainty rather than becoming independent measurements. A proposed record would retain the conversion expression, input identifiers and covariance assumptions alongside the output. If those inputs are absent, it would show a conditional calculation rather than an observed corrected value. This is useful for an application scientist deciding whether dose-normalised differences are large enough to merit another experiment or are mainly artefacts of inconsistent preparation and dilution conventions.
An acceptance rule for the comparison
Agree the denominator that makes the comparison interpretable before ranking materials or combining values from different experimental preparations.
The proposed deliverable is a denominator specification agreed before numerical pooling or ranking. It would define the measured material, concentration basis, permitted conversions and fields that must remain unreported. A partner could inspect representative source records and decide whether the rule is sufficient for its planned assay. The commercial value lies in avoiding an ambiguous test brief or a misleading literature comparison. It is not a claim that concentration normalisation guarantees formulation performance, and any laboratory measurement needed to complete the specification would have its own scope and delivery requirement.
The next proposed comparison.
A denominator and conversion specification with unresolved inputs
The next question should expose the missing input
Find the missing mass or volume input that could reverse a comparison before requesting more assays at an uncertain dose.
Before comparing two impressive percentages, ask what mass and volume were actually present at the measured stage. If the answer depends on a missing water fraction, establish whether measuring it would change the application decision. If two assays use different final matrices, a matched-dose test may still be insufficient and a common experimental protocol may be required. The proposed next step is therefore a small conversion audit followed by a clearly justified comparison. A development team should leave with a basis it can reproduce, not merely a spreadsheet in which incompatible concentrations have been made to look uniform.
Evidence engineering · Proposed development discussion
A development path
for this research.
The concentration basis required for a fair comparison
The people this could serve.Formulation, application-science and research-data teams.
The decision behind the project.
Your intended application, present alternative and the constraint behind “Concentration and mass basis”. A useful starting point is the change that would justify another development step.
A proposed scope centred on a denominator and conversion specification with unresolved inputs.
Agree the comparison, acceptance basis and responsible expertise before discussing a paid package.
Specialist methods and a defined contribution.
Bring relevant analytical or experimental expertise, a comparator suggestion, and the conditions under which your method could resolve this question.
A jointly scoped proposal could connect your contribution with a denominator and conversion specification with unresolved inputs.
Define contributions, required access, independent preparations and permitted outputs before work or protected information is shared.
The commercial purpose of the next milestone.
Bring the application or asset thesis, the buyer you expect to value it, and the scientific or commercial uncertainty that must be resolved before another commitment.
The proposed decision record would connect the buyer question with a denominator and conversion specification with unresolved inputs. It would identify what a subsequent comparison needs to demonstrate.
Demand, development cost, resources, rights and a decision-changing milestone would need examination. No financing terms or investment outcome are represented here.
What a useful comparison
would record.
- Record final mass concentration (kg m⁻³) with the preparation, method and conditions needed to interpret it.
- Record stock mass concentration (kg m⁻³) with the preparation, method and conditions needed to interpret it.
- Record stock volume added (m³) with the preparation, method and conditions needed to interpret it.
What the proposed
brief could leave behind.
- A denominator and conversion specification with unresolved inputs
- A preparation, comparator and endpoint record tied to this question.
- A source-linked account of the evidence gaps, study assumptions and next review point.
The proposed discussion brief
A brief you
can take away.
Use non-confidential notes to connect this topic with your own decision. Entries stay in this browser tab; saving creates a text file on your device. Nothing is submitted.
A scoped evidence/data decision brief or qualified comparison programme; recurring or API access only after delivery capacity and repeat buyer value are established.
Notes are optional. The brief includes this page’s proposed question and public source links.
Proposed scope; resources, methods, rights and delivery terms would be agreed before work. Begin with non-confidential information.
Sources and reading notes.
External work is identified below. Access notes describe the material inspected for this page; company research questions and proposed work are not presented as findings from these sources.
Sun et al., 2015Sun et al. (2015) Characterization and Biotechnological Potential Analysis of a New Exopolysaccharide from the Arctic Marine Bacterium Polaribacter sp. SM1127
Preparation classes, glycosyl composition and distinct crude-EPS functional assays.
Scope and limitations: External material; not Bio samples, skin efficacy or a complete ingredient specification. Retention condition wording remains unresolved.
Open original sourceSTRENDA Commission, 2021STRENDA Commission (2021) Guidelines Lists Level 1A and 1B, version 1.8
Catalyst identity, assay conditions, activity units, replicate definitions and model reporting.
Scope and limitations: Reporting guidance, not assay approval or a probabilistic quality score.
Open original sourceJCGM, 2008JCGM (2008) Evaluation of measurement data—Guide to the expression of uncertainty in measurement
Measurement models, uncertainty components and covariance in propagation.
Scope and limitations: Does not provide application tolerances or missing source covariance.
Open original sourceWoodbridge et al, 2025Woodbridge et al. (2025) Rheological Characterisation of a Carbopol Microgel and a Commercial Body Lotion: Steady, Oscillatory, and Parallel Superposition Measurements
Acquired six source CSVs: 392 flow, amplitude and frequency rows for two source specimens; source units and README conditions.
Scope and limitations: CC BY 4.0 version 1; two studied specimens, not independent lots or a current commercial product specification. No parallel-superposition or slip data analysed.
Open original source
